| Ms Yolanda A Suber, FNP-C | |
|
2615 Edwards St Ste 171, Alton, IL 62002-3915 | |
| (618) 462-4342 | |
| (618) 462-5334 |
| Full Name | Ms Yolanda A Suber |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 2615 Edwards St Ste 171, Alton, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1841842341 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 209017263 (Illinois) | Primary |
| Entity Name | Southern Illinois Healthcare Foundation, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013198712 PECOS PAC ID: 1456256874 Enrollment ID: O20031126000641 |
News Archive
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
PolyMedix, Inc. (www.polymedix.com), an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, provided an overview of its 2010 clinical milestones in a presentation by President & C.E.O., Nicholas Landekic at the 2010 BIO CEO & Investor Conference.
ARIAD Pharmaceuticals, Inc. today announced updated clinical data from an ongoing Phase 1 study of its investigational pan-BCR-ABL inhibitor, AP24534, in patients with resistant and refractory chronic myeloid leukemia (CML). The data confirm strong clinical evidence of hematologic, cytogenetic and molecular anti-leukemia activity of AP24534, a multi-targeted kinase inhibitor, in heavily pretreated patients with CML, including those with the T315I mutation of the target protein, BCR-ABL.
While the proportion of adults with severe obesity using prescription opioids initially declines in the months after bariatric surgery, it increases within a matter of years, eventually surpassing pre-surgery rates of patients using the potentially addictive pain medications, according to new research from a National Institutes of Health -funded multicenter study led by the University of Pittsburgh Graduate School of Public Health.
A team of Cochrane authors based in the UK and led by an academic from Plymouth University Peninsula Schools of Medicine and Dentistry, has carried out a review investigating the health benefit of contact with the natural environment.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Yolanda A Suber, FNP-C 2615 Edwards St Ste 171, Alton, IL 62002-3915 Ph: (618) 462-4342 | Ms Yolanda A Suber, FNP-C 2615 Edwards St Ste 171, Alton, IL 62002-3915 Ph: (618) 462-4342 |
News Archive
People are more successful in taking up healthy habits if their partner makes positive changes too, according to research published in JAMA Internal Medicine today (Monday).
PolyMedix, Inc. (www.polymedix.com), an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, provided an overview of its 2010 clinical milestones in a presentation by President & C.E.O., Nicholas Landekic at the 2010 BIO CEO & Investor Conference.
ARIAD Pharmaceuticals, Inc. today announced updated clinical data from an ongoing Phase 1 study of its investigational pan-BCR-ABL inhibitor, AP24534, in patients with resistant and refractory chronic myeloid leukemia (CML). The data confirm strong clinical evidence of hematologic, cytogenetic and molecular anti-leukemia activity of AP24534, a multi-targeted kinase inhibitor, in heavily pretreated patients with CML, including those with the T315I mutation of the target protein, BCR-ABL.
While the proportion of adults with severe obesity using prescription opioids initially declines in the months after bariatric surgery, it increases within a matter of years, eventually surpassing pre-surgery rates of patients using the potentially addictive pain medications, according to new research from a National Institutes of Health -funded multicenter study led by the University of Pittsburgh Graduate School of Public Health.
A team of Cochrane authors based in the UK and led by an academic from Plymouth University Peninsula Schools of Medicine and Dentistry, has carried out a review investigating the health benefit of contact with the natural environment.
› Verified 4 days ago
Mrs. Misty D Biciocchi, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4 Memorial Dr, Ste 134, Alton, IL 62002 Phone: 618-607-1340 Fax: 618-622-9724 | |
Lee A Tardino, MSN ANP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4 Memorial Dr Ste 210, Alton, IL 62002 Phone: 618-463-5905 Fax: 618-463-5935 | |
Jodi R Lutz, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1650 Washington Ave, Alton, IL 62002 Phone: 314-687-2735 | |
Lisa K James, ANP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4 Memorial Dr Ste 230, Alton, IL 62002 Phone: 618-433-6170 | |
Laura L Brandenburg, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4 Memorial Dr, Ste 230b, Alton, IL 62002 Phone: 618-463-7777 Fax: 618-463-7767 | |
Kelsey M Beard, FNP-BC, DNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4 Memorial Dr Ste 210, Alton, IL 62002 Phone: 618-463-5905 Fax: 618-463-5035 | |
Anissa Fay Washington, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Memorial Dr, Alton, IL 62002 Phone: 618-463-7300 |